Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01707251 · ClinicalTrials.gov registry record · Phase 4
Intravenous Ibuprofen for Laparoscopic Bariatric Surgery
A Phase 4 study, sponsored by Jacobi Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT01707251 is a Phase 4 study that has completed, run by Jacobi Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT01707251, a Phase 4 study, has completed, sponsored by Jacobi Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
Primary objective of this study is to test hypothesis that IV ibuprofen decreases 24 hours morphine requirement using IV PCA in patients after laparoscopic bariatric surgery. Secondary objective is to determine if it decreases respiratory depression measured using RD, improves area under curve (AUC) for pain scores at rest (AUCr) and with cough (AUCa) and pressure pain threshold (PPT) (important for mobilization). Tertiary objective is to compare incidence of nausea/vomiting, sedation, itching, blood transfusion, over sedation, urinary retention, GI or surgical bleeding, renal dysfunction, time to clears and baseline activity in ibuprofen and control groups.
Interventions
- DRUG Saline
- DRUG Intravenous Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01707251
The ClinicalTrials.gov registry entry for NCT01707251 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jacobi Medical Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT01707251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01707251 about?
NCT01707251 is a clinical study titled "Intravenous Ibuprofen for Laparoscopic Bariatric Surgery". Primary objective of this study is to test hypothesis that IV ibuprofen decreases 24 hours morphine requirement using IV PCA in patients after laparoscopic bariatric surgery. Secondary objective is to determine if it decreases respiratory depression measured using RD, improves area under curve (AUC)...
What is the current status of trial NCT01707251?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2012-10. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01707251?
The interventions under investigation include: Saline (DRUG), Intravenous Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT01707251?
This trial is sponsored by Jacobi Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.